Hugh Waters, MD, an associate professor at Chapel Hill-based University of North Carolina, analyzed 263,600 U.S. individuals living who sought treatment for basal cell carcinomas, squamous cell carcinomas or melanomas.
Here are three insights:
1. There were approximately 9,000 melanoma cases, 86,600 squamous cell carcinomas cases and 168,000 basal cell carcinomas cases attributed to tanning device use.
2. The treatment costs for these individuals totals $343.1 million annually.
3. Over the individuals’ lifetime, the healthcare industry will field a $127.3 billion loss.
Dr. Waters concluded, “The use of tanning devices is a significant contributor to illness and premature mortality in the United States, and also represents a major economic burden in terms of the costs of medical care and lost productivity.”
More articles on improving health:
Comparing primary care to concierge core: Which is more costly?
SurgiCenter of Vineland’s Dr. Karl Holzinger offers eye surgery to Cambodia residents: 4 points
Vail Valley Surgery Center donates $764k to 29 nonprofits: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
